Wegovy isn't FDA-approved to treat type 2 diabetes — that's Ozempic's job. Here's what that actually means if you have diabetes.
Wegovy is not FDA-approved for type 2 diabetes. Ozempic — the same active ingredient, semaglutide, at a lower max dose — holds that approval. Having diabetes doesn't disqualify you from Wegovy, but it isn't the on-label diabetes drug.
Per FDA-approved prescribing information for Wegovy and Ozempic, Novo Nordisk. Not medical advice — talk to your prescriber about which drug fits your diagnosis and goals.
Notice the pattern: each active ingredient has one brand approved for diabetes and a separate brand approved for weight management, even though the drug itself is the same molecule.
Having type 2 diabetes doesn't prevent you from being prescribed Wegovy for weight management.
Losing weight often improves insulin sensitivity and blood sugar control, even on a drug not labeled for diabetes.
Your prescriber will still manage your diabetes treatment separately — Wegovy isn't a substitute for that plan.
If treating diabetes is the primary goal, Ozempic (or Mounjaro) is the FDA-approved option built for that.
Coverage usually tracks the approved indication — a diabetes diagnosis alone won't automatically get Wegovy covered.
The right drug depends on which goal — diabetes control or weight management — is the priority right now.
One email at launch · free trial · no credit card